Farbiopharma S.A. Company Profile - Ecuador | Financials & Key Executives

Farbiopharma S.A. is based in Ecuador. The head office is in Quito. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on July 27, 2001. The total number of employees is currently 332 (2023). From the latest financial highlights, Farbiopharma S.A. reported a net sales revenue increase of 3.28% in 2023. Its total assets grew by 21.97% over the same period. The enterprise’s net profit margin decreased by 0.72% in 2023.

Headquarters
Guayas E3-296
Quito; Pichincha;

Contact Details: Purchase the Farbiopharma S.A. report to view the information.

Website: http://www.farbiopharma.com

Basic Information

Total Employees:

Purchase the Farbiopharma S.A. report to view the information.

Outstanding Shares:

Purchase the Farbiopharma S.A. report to view the information.

Registered Capital:

Purchase the Farbiopharma S.A. report to view the information.

Incorporation Date:

July 27, 2001

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Farbiopharma S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

3.28%▲

Total operating revenue

2.76%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

-6.96%▼

Total assets

21.97%▲

Total equity

14.72%▲

Operating Profit Margin (ROS)

N/A

Net Profit Margin

-0.72%▼

Return on Equity (ROE)

-2.84%▼

Debt to Equity Ratio

15.07%▲

Quick Ratio

-0%

Cash Ratio

Farbiopharma S.A. (Ecuador)

Similar companies

Related EMIS Industry Reports